Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.

Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy -especially among genotype 1 infected patients-, is costly, and involves severe side effects. Thus, predicting non-response is of major interest for both patient wellbeing and health care expense. At present, treatme...

Full description

Bibliographic Details
Main Authors: Verónica Saludes, Maria Alma Bracho, Oliver Valero, Mercè Ardèvol, Ramón Planas, Fernando González-Candelas, Vicente Ausina, Elisa Martró
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-11-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2994723?pdf=render